ConvaTec Group Plc

Scrip Dividend - Total Issued Shares

Reading, United Kingdom (28 September 2021)

The Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend in respect of 2021 of 1.717 cents per share ("Interim Dividend"). The Interim Dividend is to be paid on 14 October 2021 to shareholders on the share register at 3 September 2021 ("Record Date"). The dividend is payable in cash in sterling to holders of ordinary shares. On 30 July 2021, the Company announced that a scrip dividend would be made available for the Interim Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares. The calculation price for the scrip dividend was announced on 9 September 2021.

It is confirmed that 750,265 new ordinary shares of 10 pence each will be allotted and issued on 14 October 2021 by the Company to those shareholders who elected to receive the scrip dividend alternative. The shares will rank pari passu with the existing issued ordinary shares of the Company. Application will be made to the Financial Conduct Authority for the shares to be admitted to the Official List and to the London Stock Exchange for the shares to be admitted to trading.

Following the issue of shares under the scrip dividend scheme in respect of the Interim Dividend, the Company's issued share capital will be 2,014,572,935 ordinary shares of 10 pence each.

Dealings in the shares issued under the scrip dividend scheme are expected to commence on 14 October 2021.

Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Interim Dividend are:

Rules and share certificates, CREST accounts credited/updated,

and first day of dealings in New Shares

Enquiries

Analysts and Investors

Kate Postans, VP, Investor Relations &                                                  +44 (0)782 644 7807

Corporate Communications                                                       

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane                                                +44 (0)207 466 5000                                                                                                          

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

# # #

END